|
Volumn 25, Issue 13, 1998, Pages 2075-2084
|
Phase I study of raltitrexed (ZD-1694)
a a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ANTINEOPLASTIC ANTIMETABOLITE;
ASPARTATE AMINOTRANSFERASE;
ENZYME INHIBITOR;
QUINAZOLINE DERIVATIVE;
RALTITREXED;
THIOPHENE DERIVATIVE;
THYMIDYLATE SYNTHASE;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
BLOOD;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COLON TUMOR;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG TUMOR;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
NAUSEA;
NEOPLASM;
PHASE 1 CLINICAL TRIAL;
ADULT;
AGED;
ALANINE TRANSAMINASE;
ANOREXIA;
ANTIMETABOLITES, ANTINEOPLASTIC;
ASPARTATE AMINOTRANSFERASES;
COLONIC NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NAUSEA;
NEOPLASMS;
QUINAZOLINES;
THIOPHENES;
THYMIDYLATE SYNTHASE;
|
EID: 0032214626
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|